Position in HIMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,350,812
-$10,755,880 QoQ
Shares Held
38,962
-93.3% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#193
of 506 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $298,952,947 across 6 Drug Manufacturers - Specialty & Generic names. HIMS ranks #5 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
3,601,472 | $188,717,132 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
546,961 | $60,679,853 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
1,694,717 | $41,706,985 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
166,867 | $5,653,453 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
This page
|
38,962 | $1,350,812 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,559 | $844,712 |
All Filings in HIMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,350,812 | 38,962 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,106,692 | 583,174 | Shares | Sole | 2026-05-15 | |
| 2023-03-31 | $480,762 | 48,464 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $126,662 | 23,764 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,007,575 | 306,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,954,503 | 259,218 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $431,058 | 39,583 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||